In addition to SmHMGR, there are a number of other enzymes downstream in the pathway that could be interrogated for development of an anti-parasite therapy based on clinical precedent in oncology (farnesyl transferase [70]–[73]) and osteoporosis (farnesyl diphosphate synthase [4], [74], [75]). Here, FDPS is linked to osteoporosis.